About Zentiva
Zentiva is a Healthcare company based in Prague (Czechia) founded in 1958, and was acquired by Aurobindo Pharma in August 2025. Pharmaceutical products are manufactured and developed by Zentiva in Prague. Zentiva has completed 4 acquisitions, including Bewell, Blokurima and Creo Pharma. Its chief executive, as recorded, is Steffen Saltofte. Zentiva offers products and services including Generic Medicines and Biosimilars. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas. Its legal entity is Zentiva Group, a.s.
Company details
Zentiva was established in 1958 and is based in Prague, Czech Republic. Operations in the pharmaceutical sector are centered on manufacturing and developing generic and branded medicines. Products are distributed across European and international markets, with a focus on therapeutic areas such as cardiology and gastroenterology. Leadership is provided by CEOs Steffen Saltofte and Nick Haggar, overseeing production facilities and regulatory compliance in the industry.
- Headquarters Prague, Czechia
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website zentiva.com
- Social LinkedIn YouTube
- Acquired by Advent International (Apr 2018)
- Legal Name Zentiva Group, A.S
Products & Services of Zentiva
Zentiva offers a comprehensive portfolio of products and services, including Generic Medicines and Biosimilars.
Generic medicines are produced by Zentiva as equivalents to branded drugs for various health needs.
Biosimilars are supplied by Zentiva through license agreements for commercialization in global markets.
Apps and channels of Zentiva
its YouTube channel Zentiva Italia has 1.29K subscribers and 30 videos.
Videos from Zentiva
The most watched videos on Zentiva's YouTube channel, Zentiva Italia (1.29K subscribers). Click a video to play it here.
More on Zentiva Italia.
Funding Insights of Zentiva
- Total Rounds 4
- Last Round Grant — $488,376
- First Round $324,266
(Jan 2018)
- Investors Count 2
All 4 funding rounds of Zentiva with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2023 | $488,376 | Grant | – | – | |
| Jan 2021 | $288,039 | Grant | – | – | |
| Mar 2018 | $13,022 | Grant | – | – | – |
| Jan 2018 | $324,266 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Zentiva
Zentiva has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Sanofi, Aurobindo Pharma and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on multiple sectors | adventinternational.com | Sao Paulo, Brazil | ||
A digital platform for public administration services in Czech Republic. | gov.cz | Czech Republic | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Pharmaceutical and nutraceutical products are developed across seven therapeutic areas. | 1973 | sanofi.com | Paris, France | |
Generic biocatalytic solutions are provided for pharmaceutical applications. | 1986 | aurobindo.com | Hyderabad, India |
Investor details for Zentiva
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Zentiva
95 people are tracked at Zentiva (48 in leadership, 47 in team).
| Name | Role | Group |
|---|---|---|
Steffen Saltofte | CEO | Leadership |
Nick Haggar | CEO | Leadership |
Karlis Ozols | Head Of Finance Noban | Leadership |
Kenneth Lynard | Board Member & Group CFO ▶ Private Equity ● Transformation ● Strong Growth ● Cash ● Investors | Leadership |
Teodora Mikova | ITS Business Partner | Leadership |
Pawel Stasiak | Pharma Development Director | Leadership |
Oleksandr Poljanyčka | Head Of Data Insights And Analytics | Leadership |
Anita Fiksdal | Commercial Director, Nordics | Leadership |
Maxime Choisel | Head Of Talent Acquisition | Leadership |
Jaroslav Lupač | Head Of IT Industrial Operations And Supply Chain | Leadership |
Natalia Maslennikova | Head Of Legal & Compliance | Leadership |
Valeria Alvarez | CFO Italy | Leadership |
Javier Gamez | Head Of Commercial | Leadership |
John Leach | Head Of Transformation | Leadership |
Ivan Radosavljevic | Head Of Finance Product Supply | Leadership |
Hynek Ruta | Head Of IT Operations | Leadership |
Karin Stamm | Head Of Finance, HR & IT | Leadership |
Bruno Maugée | CFO Zentiva France | Leadership |
Petra Valentova | Head Of Prague Scientific | Leadership |
Anant Atal | Chief Strategy, Transformation & Corporate Development Officer | Leadership |
75 more people are available in the full profile.
Complete people profiles for Zentiva
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zentiva
Zentiva has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Bewell, Blokurima and Creo Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Retailer of supplements supporting urinary tract health and overall wellness | blokurima.cz | 0 | Jan 2025 | •••• | ||
Distributor of generic drugs | creopharma.com | Felsted, United Kingdom | 2007 | Apr 2019 | •••• | |
Generic drugs are manufactured by Solacium in Romania. | solacium.ro | Romania | 2009 | Mar 2019 | •••• | |
Brand of chimneys, water purifiers and stoves & hobs | bewell.co.in | Ghaziabad, India | 2019 | Mar 2019 | •••• |
Complete acquisition details for Zentiva
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Zentiva
10 dated milestones of Zentiva across 67 years, from founding to its latest funding, stage changes and deals.
- Founded Zentiva is founded.
- Exit Acquired by Sanofi.
- Funding First funding round of $324K.
- Exit Acquired by Advent International.
- Acquisition Acquires Bewell.
- Acquisition Acquires Solacium.
- Acquisition Acquires Creo Pharma.
- Funding Latest funding round, Grant, of $488K.
- Acquisition Acquires Blokurima.
- Exit Acquired by Aurobindo Pharma.
Web traffic of Zentiva
The website of Zentiva (zentiva.com) receives about 9.9K visits a month and ranks #2,071,369 among all websites worldwide, #2,823 in Biotechnology and Pharmaceuticals.
- Monthly visits9.9K
▼ 3.8% vs previous month
- Unique visitors4.5K
per month
- Global rank#2,071,369
among all websites
- Category rank#2,823
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit2.0
- Average visit18 sec
- DevicesDesktop 51% · Mobile 49%
Websites whose visitors overlap most with Zentiva. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
helvepharm.ch | helvepharm.ch | 100% | – | ||
| sandoz.com | 100% | 195.3K | #232,061 | View details | |
| gabionline.net | 100% | #1,546,519 | View details | ||
sanofi.co.za | sanofi.co.za | 100% | – | ||
| bellcogenerics.com | 99% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Zentiva
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zentiva
Complete news archive for Zentiva
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zentiva
Zentiva was founded in 1958 and raised its 1st funding round 60 years after it was founded.
Zentiva is headquartered in Prague, Czechia.
Steffen Saltofte is the CEO of Zentiva, as recorded in our data.
Zentiva was established in 1958 and is based in Prague, Czech Republic. Operations in the pharmaceutical sector are centered on manufacturing and developing generic and branded medicines. Products are distributed across European and international markets, with a focus on therapeutic areas such as cardiology and gastroenterology. Leadership is provided by CEOs Steffen Saltofte and Nick Haggar, overseeing production facilities and regulatory compliance in the industry.
Zentiva offers Generic Medicines and Biosimilars.
Zentiva has made 4 acquisitions, including Bewell, Blokurima, and Creo Pharma.
Zentiva has 5 investors. Key investors include Sanofi, Aurobindo Pharma, European Union, Portál veřejné správy, and Advent International.
Zentiva operates through Zentiva Group, A.S.
Yes. Zentiva was acquired by Advent International in April 2018.